Protein kinase B/Akt modulators and methods for the use thereof
AssigneeThe Salk Institute for Biological Studies
InventorsKeyong Du, Stephan Herzig, Marc Montminy
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Salk Institute for Biological Studies
InventorsKeyong Du, Stephan Herzig, Marc Montminy
Estimating the term…
The present invention describes modulator of protein kinase B (PKB)/Akt proteins, exemplified by the Tribbles (TRB) family. An exemplary member of the TRB family, TRB-3, binds to Akt and inhibits its catalytic activity, in turn causing altered regulation of glucose metabolism pathways. TRB-3 expression is strongly induced in the fasting state, and upregulated in mouse models of type II, causing disruptions in insulin signaling. Accordingly, the present invention further provides compositions and methods for disrupting the interaction between such a modulator and PKB/Akt protein kinases. Also provided are methods of determining if a subject has a predisposition to impaired glucose regulation and methods for treating diabetes mellitus using invention compositions.
A method for screening test compounds to determine if any disrupt the interaction between an inhibitor of protein kinase B (PKB)/Akt protein and a PKB/Akt protein, said method comprising:
A method for identifying a compound that disrupts the interaction between an inhibitor of PKB/Akt protein and a PKB/Akt protein, said method comprising:
A method for screening test compounds to determine if any affect the phosphorylation state of a mammalian protein kinase B (PKB)/Akt protein kinase, said method comprising:
Dependencies are inferred from the claim text.